Gapping down
In reaction to disappointing earnings/guidance:
- ROX -7.1%, FNSR -3.8%, ADBE -2.9%
Other news:
- GNK -8.1% (commences public offering of common stock)
- AI -8.1% (declares quarterly $0.375 per common share dividend, down from prior $0.55 per share)
- CISN -6.9% (prices secondary offering by selling shareholders of $12 mln shares of common stock at $15.00 per share)
- AFMD -6.1% (presents new interim data from Phase 1b dose escalation study evaluating AFM13 -- best response data from 18 patients confirms favorable safety profile and overall response rate of 89%)
- GFF -3.2% (secondary offering by selling shareholders of 4,855,109 shares of its common stock at $18.00)
- PSTG -3% (indicated lower on block trade pricing)
- JCP -1.5% (estimates corporate aircraft assets impairment charge to be approx $50 mln)
Analyst comments:
- CLDR -2.6% (initiated with Reduce rating at Nomura Instinet)
- ATI -2.4% (downgraded to Underweight from Neutral at JP Morgan)
- ROIC -1.1% (downgraded to Underweight from Neutral at JP Morgan)
- LUV -0.9% (downgraded to Hold from Buy at Argus)
![]()